The Latest Life Sciences Tools & Diagnostics Articles from Streetwise Reports

Telemedicine Co. Sees Record Revenues on Software, Services Sales

  ()
Reliq Health Technologies Inc. reports that software and services revenue continues to increase, leading to record cash intake for the quarter that ended Dec. 31, 2022.

AI-Infused Telehealth Platform Absorbs New Patients

  ()
Telemedicine company Reliq Health Technologies Inc., which uses artificial intelligence in its software's algorithms, has gained six new contracts and more than 3,000 new patients.

Former Investment Officer of One of the World's Largest Sovereign Wealth Funds Shares His Current Focus

  ()
Streetwise Reports sat down with Řyvind Schanke, the chief investment officer of TD Veen and the former investment officer of one of the world's largest sovereign wealth funds as he shares his current focus.

Telehealth Co. Expects More Growth in 2023

  ()
Officials at telemedicine company Reliq Health Technologies say they expect to accelerate growth "significantly" in 2023, which could lead to a share buyback program.

Expert Says Health Tech Co. Is in Another Buy Spot

Contributed Opinion
  ()
Expert Clive Maund reviews the 1-year chart for Reliq Health Technologies to tell you why he believes it is in another buy spot.

Expert Says Health Tech Co. Still in Good Spot To Buy

Contributed Opinion
  ()
Technical analyst Clive Maund reviews the 1-year chart for Reliq Health Technologies to tell you whether he believes it is a Buy.

Telemedicine Co. Surges on Revenue News

  ()
As internet-enabled health care becomes more accepted in the wake of the pandemic, telemedicine company Reliq Health Technologies Inc. is seeing its revenue soar.

Showing Results: 1 to 9 of 9